Spire issues profit warning as NHS reins in spending on independent sector activity

Spire Healthcare has warned that full-year EBITDA will be around the bottom end of its guidance for FY25 as NHS commissioners continue to rein in spending on independent sector activity. Group adjusted EBITDA is expected to range between £270m and £285m by the year end, despite £30m of savings from the transformation programme announced earlier…